Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Oruka Therapeutics, Inc.(ORKA) | 4,148,428 | 4,148,428 | 0 | $394.81M | $345.52M | 16.79% | -$49.28M |
| Erasca, Inc.(ERAS) | 17,891,812 | 20,089,932 | +2,198,120 | $327.78M | $294.52M | 14.31% | -$33.26M |
| Spyre Therapeutics, Inc.(SYRE) | 2,985,448 | 2,485,448 | -500,000 | $265.05M | $221.28M | 10.75% | -$43.77M |
| Korsana Biosciences Inc | 0 | 4,549,585 | +4,549,585 | $0 | $145.59M | 7.07% | +$145.59M |
| Savara Inc.(SVRA) | 14,745,943 | 19,568,534 | +4,822,591 | $90.84M | $100.97M | 4.91% | +$10.14M |
| Ocular Therapeutix, Inc.(OCUL) | 10,346,926 | 10,346,926 | 0 | $101.61M | $79.36M | 3.86% | -$22.25M |
| Damora Therapeutics Inc | 0 | 3,603,595 | +3,603,595 | $0 | $76.68M | 3.73% | +$76.68M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,180,000 | 822,020 | -357,980 | $115.03M | $72.38M | 3.52% | -$42.65M |
| Viridian Therapeutics, Inc.(VRDN) | 3,257,917 | 3,257,917 | 0 | $59.85M | $67.08M | 3.26% | +$7.23M |
| Vor Biopharma Inc.(VOR) | 3,041,719 | 3,041,719 | 0 | $56.00M | $58.04M | 2.82% | +$2.04M |
| Cogent Biosciences, Inc.(COGT) | 1,642,166 | 1,642,166 | 0 | $63.55M | $52.58M | 2.55% | -$10.97M |
| Adlai Nortye Group LtdADS | 3,212,731 | 3,212,731 | 0 | $36.95M | $51.40M | 2.50% | +$14.46M |
| Jade Biosciences Inc | 3,220,364 | 3,220,364 | 0 | $71.56M | $45.25M | 2.20% | -$26.31M |
| Achieve Life Science Inc | 2,751,032 | 5,502,064 | +2,751,032 | $17.96M | $44.51M | 2.16% | +$26.55M |
| Maze Therapeutics, Inc.(MAZE) | 1,602,034 | 1,545,616 | -56,418 | $47.80M | $42.01M | 2.04% | -$5.79M |
| Oric Pharmaceuticals Inc | 4,319,765 | 2,944,056 | -1,375,709 | $46.78M | $39.66M | 1.93% | -$7.13M |
| Dyne Therapeutics, Inc.(DYN) | 2,173,913 | 2,173,913 | 0 | $48.28M | $35.02M | 1.70% | -$13.26M |
| Adarx Pharmaceuticals Inc | 0 | 1,625,793 | +1,625,793 | $0 | $32.42M | 1.58% | +$32.42M |
| Crescent Biopharma Inc. | 2,133,576 | 2,133,734 | +158 | $38.40M | $31.13M | 1.51% | -$7.27M |
| Relmada Therapeutics Inc | 6,844,305 | 7,445,050 | +600,745 | $47.36M | $28.07M | 1.36% | -$19.29M |
| Zura Bio LtdCL A | 6,434,990 | 6,434,990 | 0 | $37.97M | $26.77M | 1.30% | -$11.20M |
| X4 Pharmaceuticals Inc | 1,934,253 | 7,644,072 | +5,709,819 | $9.03M | $22.17M | 1.08% | +$13.13M |
| Cullinan Therapeutics Inc | 1,379,965 | 1,379,965 | 0 | $25.13M | $21.18M | 1.03% | -$3.95M |
| Surrozen Inc | 632,931 | 632,931 | 0 | $16.42M | $20.37M | 0.99% | +$3.94M |
| Parabilis Medicines Inc | 625,000 | 625,000 | 0 | $17.11M | $20.18M | 0.98% | +$3.08M |
| Arvinas Inc | 0 | 1,952,533 | +1,952,533 | $0 | $15.10M | 0.73% | +$15.10M |
| Century Therapeutics Inc | 8,695,652 | 8,695,652 | 0 | $21.30M | $14.87M | 0.72% | -$6.43M |
| Entera Bio LtdSHS | 0 | 5,106,337 | +5,106,337 | $0 | $14.86M | 0.72% | +$14.86M |
| Artiva Biotherapeutics Inc | 2,043,596 | 2,043,596 | 0 | $19.82M | $14.55M | 0.71% | -$5.27M |
| Alto Neuroscience, Inc.(ANRO) | 500,000 | 500,000 | 0 | $13.20M | $12.77M | 0.62% | -$430.0K |
| Korro Bio Inc | 1,009,500 | 443,431 | -566,069 | $13.31M | $4.39M | 0.21% | -$8.91M |
| Tcgx Acquisition CorpCL A | 0 | 300,000 | +300,000 | $0 | $3.75M | 0.18% | +$3.75M |
| Research Alliance Corp IvCL A | 0 | 300,000 | +300,000 | $0 | $3.60M | 0.17% | +$3.60M |
| Inmed Pharmaceuticals Inc | 32,685 | 133,378 | +100,693 | $50.7K | $181.4K | 0.01% | +$130.7K |
| Apogee Therapeutics Inc | 8,493,321 | 0 | -8,493,321 | $1.13B | $0 | — | -$1.13B |
| Helus Pharma Inc(HELP) | 3,851,654 | 0 | -3,851,654 | $25.46M | $0 | — | -$25.46M |
| CytomX Therapeutics, Inc.(CTMX) | 4,982,124 | 0 | -4,982,124 | $18.68M | $0 | — | -$18.68M |
| Damora Therapeutics, Inc.(DMRA) | 3,603,595 | 0 | -3,603,595 | $93.73M | $0 | — | -$93.73M |
| Enliven Therapeutics Inc | 526,331 | 0 | -526,331 | $26.71M | $0 | — | -$26.71M |
| Research Alliance Corp IiiCL A | 300,000 | 0 | -300,000 | $3.21M | $0 | — | -$3.21M |